Patents by Inventor Fritz Henn

Fritz Henn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8415344
    Abstract: Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K+ channel openers and ?-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: April 9, 2013
    Assignee: Brookhaven Science Associates, LLC
    Inventor: Fritz Henn
  • Publication number: 20120129826
    Abstract: Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K+ channel openers and ?-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.
    Type: Application
    Filed: November 30, 2011
    Publication date: May 24, 2012
    Applicant: Brookhaven Science Associates, LLC
    Inventor: Fritz Henn
  • Patent number: 8101600
    Abstract: Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K+ channel openers and ?-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: January 24, 2012
    Assignee: Brookhaven Science Associates, LLC
    Inventor: Fritz Henn
  • Publication number: 20100160300
    Abstract: Methods for treatment of depression-related mood disorders in mammals, particularly humans are disclosed. The methods of the invention include administration of compounds capable of enhancing glutamate transporter activity in the brain of mammals suffering from depression. ATP-sensitive K+ channel openers and ?-lactam antibiotics are used to enhance glutamate transport and to treat depression-related mood disorders and depressive symptoms.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 24, 2010
    Applicant: Brookhaven Science Associates, LLC
    Inventor: Fritz Henn